(
out of
219
reviews
)
Clinical Locations
Primary Location
Huntsman Cancer Institute - Cancer Hospital South
Radiation Oncology
1950 Circle of Hope
Salt Lake City
,
UT
84112
Board Certification
|
American Board of Radiology (Radiation Oncology)
|
Patient Rating
Patients consistently describe Dr. Cannon as knowledgeable, compassionate, and thorough, noting that he listens attentively and makes them feel heard and comfortable. Reviewers emphasize clear, patient explanations of treatment options, timing, and potential side effects, with complex procedures explained in understandable terms. Many report confidence in his care, responsiveness, and empathy throughout cancer treatment and express gratitude for positive outcomes.
Generated via Patient Reviews
5.0
/5
( out of
219 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Radiation Oncology
-Associate Professor (Clinical) |
|---|---|
| Board Certification |
American Board of Radiology (Radiation Oncology)
|
Education history
| Chief Resident | Radiation Oncology - University of Wisconsin Hospital & Clinics | Chief Resident |
|---|---|---|
| Residency | Radiation Oncology - University of Wisconsin Hospital & Clinics | Resident |
| Internship | Internal Medicine - University of Utah School of Medicine | Intern |
| Professional Medical | Medicine - Weill Cornell Medical College | M.D. |
| Undergraduate | Major: Physics; Minor: Mathematics - Brigham Young University | B.S. |
Selected Publications
Journal Article
- Poppe MM, Boucher K, Gaffney DK, Brownson KE, Smith G, Howell JN, Ticona FF, Kim J, Burt L, Cannon D, Kokeny K (2025). NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Therapy With a Simultaneous Lumpectomy Boost for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys, 123(1), 141-149.
- Weil CR, Rock CB, Sarkar V, Gravbrot N, Lew FH, Rock CB, Burt LM, DeCesaris CM, Jensen RL, Shrieve DC, Cannon DM (2025). Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas. Am J Clin Oncol, 48(8), 403-409.
- Williamson J, Fadlullah MZH, Kovacsovics-Bankowski M, Gibson B, Swami U, Erickson-Wayman A, Jamison D, Sageser D, Jeter J, Bowles TL, Cannon DM, Haaland B, Schroeder JD, Nix DA, Atkinson A, Hyngstrom J, McPherson J, Tan AC, Hu-Lieskovan S (2025). Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma. Curr Oncol, 32(3).
- Robinson LJ, Goold E, Cannon DM, Mendez JS, Menacho ST, Mao Q, Liu T (2024). A rare case of an adult primary intracranial sarcoma associated with a DICER1 mutation. J Neuropathol Exp Neurol, 83(5), 365-369.
- Williamson J, Fadlullah MZH, Kovacsovics-Bankowski M, Gibson B, Swami U, Erickson-Wayman A, Jamison D, Sageser D, Jeter J, Bowles T, Cannon DM, Haaland B, Schroeder JD, Nix D, Atkinson A, Hyngstrom J, McPherson J, Tan AC, Hu-Lieskovan S (2023). Response to high dose ipilimumab plus temozolomide after progression on standard or low dose ipilimumab in advanced melanoma: a retrospective analysis. Res Sq, rs.3.rs-2997157.
- Okwundu N, Weil CR, Soares HP, Fine GC, Cannon DM (2023). Case report: Efficacy of lutetium-177 oxodotreotide for neuroendocrine tumor with central nervous system metastases. Front Nucl Med, 3.
- Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala MM, Nagpal S, Nedzi LA, Nevel K, Nghiemphu PL, Parney I, Patel TR, Peters K, Puduvalli VK, Rockhill J, Rusthoven C, Shonka N, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow S (2023). NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022. J Natl Compr Canc Netw, 21(1), 12-20.
- Hutten R, Khouri A, Parsons M, Tward A, Wilson T, Peterson J, Morrell G, Dechet C, ONeil B, Schmidt B, Kokeny K, Lloyd S, Cannon D, Tward J, Sanchez A, Johnson S (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clin Genitourin Cancer, 20(6), e453-e459.
- Kundu B, Brock AA, Garry JG, Jensen RL, Burt LM, Cannon DM, Shrieve DC, Rolston JD (2022). Outcomes using linear accelerator stereotactic radiosurgery for the treatment of trigeminal neuralgia: A single-center, retrospective study. Surg Neurol Int, 13, 246.
- Kraus RD, Weil CR, Frances Su FC, Cannon DM, Burt LM, Mendez JS (2022). Incidence and extent of disease progression on MRI between surgery and initiation of radiotherapy in glioblastoma patients. Neurooncol Pract, 9(5), 380-389.
- Peterson JS, Peckham ME, Poppe MM, Burt LS, Shrieve DC, Cannon DM (2022). Delineating the Subarachnoid Space in the Adult Lumbosacral Spine Using Computed Tomographic Myelography: An Aid for Clinical Target Volume Delineation in Craniospinal Irradiation. Adv Radiat Oncol, 7(5), 100994.
- Fenlon JB, Hutten RJ, Weil CR, Lloyd S, Cannon DM, Kerrigan K, Cannon RB, Hitchcock YJ (2022). Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins. Head Neck, 44(3), 606-614.
- Fenlon JB, Hutten RJ, Weil CR, Lloyd S, Cannon DM, Kerrigan K, Cannon RB, Hitchcock YJ (2021). Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins. Head Neck, 44(3), 606-614.
- Peterson JS, Peckham ME, Poppe MM, Burt LS, Shrieve DC, Cannon DM (IN SUBMISSION). Delineating the Sub-Arachnoid Space in the Adult Lumbosacral Spine Using CT Myelography: An Aid for Clinical Target Volume Delineation in Craniospinal Irradiation. Adv Radiat Oncol.
- Kraus RD, Weil CR, Wells S, Tward JD, Groundland JS, Jones KB, Cannon DM (2021). Radiation Therapy in Conjunction With Surgical Stabilization of Impending or Pathologic Fractures Secondary to Metastasis: Is There a Difference Between Single and Multifraction Regimens? Adv Radiat Oncol, 7(2), 100795.
- Parsons MW, Whipple NW, Poppe MM, Mendez JS, Cannon DM, Burt LM (2021). The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma. J Neurooncol, 151(2), 93-101.
- Tward JD, ONeil B, Boucher K, Kokeny K, Lowrance WT, Lloyd S, Cannon D, Stephenson RA, Agarwal N, Farr T, Petragallo R, Sherar NZ, Kunz I, Hofer A, Courdy S, Shrieve DC, Dechet C (2020). Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy. Clin Genitourin Cancer, 18(4), 274-283.e5.
- Ager BJ, Torgeson A, Francis SR, Burt LM, Gaffney DK, Cannon DM (2019). Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation. Am J Clin Oncol, 43(1), 35-42.
- Cannon RB, Kull AJ, Carpenter PS, Francis S, Buchmann LO, Monroe MM, Lloyd S, Hitchcock YJ, Cannon D, Weis JR, Houlton JJ, Hunt JP (2019). Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival: Analysis of the National Cancer Database. Head Neck, 41(6), 1873-1879.
- Torrecillas V, Shepherd HM, Francis S, Buchmann LO, Monroe MM, Lloyd S, Cannon D, Hitchcock YJ, Weis JR, Hunt JP, Houlton JJ, Cannon RB (2018 Oct). Adjuvant radiation for T1-2N1 oral cavity cancer survival outcomes and utilization treatment trends: Analysis of the SEER database. Oral Oncol, 85, 1-7.
- Lippert D, Dang P, Cannon D, Harari PM, McCulloch TM, Hoffman MR, Hartig GK (9/2017). Lymph Node Yield in Therapeutic Neck Dissection: Impact of Dissection Levels and Prior Radiotherapy. Ann Otol Rhinol Laryngol.
- Morris ZS, Cannon DM, Morris BA, Bentzen SM, Kozak KR (2015). Impact of a Contralateral Tumor Nodule on Survival in Non-Small-Cell Lung Cancer. J Thorac Oncol, 10(11), 1608-15.
- Cannon DM, Mohindra P, Gondi V, Kruser TJ, Kozak KR (2015). Choroid plexus tumor epidemiology and outcomes: implications for surgical and radiotherapeutic management. J Neurooncol, 121(1), 151-7.
- Cannon DM, Geye HM, Hartig GK, Traynor AM, Hoang T, McCulloch TM, Wiederholt PA, Chappell RJ, Harari PM (2014). Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy. Head Neck, 36(8), 1120-5.
- Cannon DM, Kruser TJ, Khuntia D (2011). Principles and Application of PET in Brain Tumors. PET Clin, 6(2), 131-48.
Review
- Parsons MW, Whipple NS, Poppe MM, Mendez JS, Cannon DM, Burt LM (2020). The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma. [Review]. J Neurooncol, 151(2), 93-101.
Abstract
- Lew F, Weil CR, Rock CB, Rock CB, Burt LM, Decesaris C, Jensen RL, Shrieve DC, Cannon DM (2022). Effects of Expansion Size from Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Conventionally Fractionated Radiotherapy for WHO Grade I Meningiomas [Abstract]. 114(3), e45-e46.
- Weil CR, Rock CR, Vikren S, Gravbrot Ni, Lew FH, Rock CB, Burt LM, DeCesaris CM, Jensen RJ, Shrieve DC, Cannon DM (2022). Effects of expansion size from gross tumor volume (GTV) to planning target volume (PTV) on control rates and patterns of recurrence in conventionally fractionated radiotherapy for WHO grade 1 meningiomas [Abstract].
Dr. Cannon is an excellent Radiology-Oncologist at the Huntsman, U of Utah, Salt Lake City, Utah. He listens to you and care deeply about the perfect care for you! He tells you in a way that makes you feel heard and listened to. He's the best.
Dr. Cannon is a great doctor. He leaves you feeling like you've been seen and heard by an expert in radiation oncology.
He really cares and is so patient .
Dr. Cannon is thorough and compassionate. Excellent Radiation Oncologist!
He was very interested and responsive to my wishes.
I think Dr. Cannon is an excellent Doctor. He listens to his patients and then suggests the best care for their healthy outcome.
I think Dr. Cannon provides the best cancer care available to his patients.
Revied my chart information and determined all is looking good and trending in a positive direction.
Dr Cannon is kind, caring and knowledgeable. He makes you feel heard and comfortable. Highly recommend. 10/10 provider.
He is very open about options and timing, as well as explaining a very complicated procedure in a simple and understandable way. He openly discusses potential side effects and impacts for every option, including not choosing treatment.
dr. Cannon was very knowledgeable about the problems that I had and options that were available.
I was very impressed with Dr. Cannon and gained tremendous confidence in talking to him about my upcoming procedure
Doctor Cannon really helped me with an intra-cranial tumor and I'm doing very well. Huntsman is a top notch treatment center.